Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[The influence of locomotor treatment using robotic body-weight-supported treadmill training on rehabilitation outcome of patients suffering from neurological disorders].
Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis.
Balance impairment in people with multiple sclerosis: Preliminary evidence for the Balance Evaluation Systems Test.
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.
Regional Susceptibility to TNF-α Induction of Murine Brain Inflammation via Classical IKK/NF-κB Signalling.
Centocor briefing document for Ustekinumab, submitted to FDA
Identification of the LDL Receptor-Related Protein-1 Interactome in Central Nervous System myelin suggests a role in the clearance of necrotic cell debris.
High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis.
Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions.
European Congress of Immunology 2012
Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE(R) Patent
Comparing the biological impact of glatiramer acetate with the biological impact of a generic.
Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients.
Durable pharmacological responses from the peptide drug ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.
Therapeutic Testosterone Administration Preserves Excitatory Synaptic Transmission in the Hippocampus during Autoimmune Demyelinating Disease.
Amiloride HCl

Pages